Cristián Barros-Osorio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cristián Barros-Osorio has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Walter Sepúlveda-Loyola
Faculty of Health and Social Sciences, Center for Research in Biological and Chemical Sciences, Universidad de Las Américas, Santiago 7500975, Chile
3 shared publications - Catalina Ramírez-López
Institute of Biomedical Sciences, Faculty of Health Sciences, Universidad Autónoma de Chile, Santiago 8581151, Chile
2 shared publications - Eduardo Sandoval-Obando
Facultad de Ciencias Sociales y Humanidades, Universidad Autonoma de Chile, Chile
2 shared publications - Fernando C. Ortiz
Mechanisms of Myelin Formation and Repair Laboratory, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
2 shared publications - Francisca Cornejo
Center for Integrative Biology, Faculty of Science, Universidad Mayor, Santiago 8580745, Chile
2 shared publications - Francisca Rodríguez-Arriaza
Mechanisms of Myelin Formation and Repair Laboratory, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago 8350347, Chile
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8320
Exploring Artificial Intelligence Models for the Detection and Prediction of Sarcopenia: A Scoping Review
Background/Objectives: Sarcopenia is a progressive skeletal muscle disorder associated with adverse health outcomes, including disability, hospitalization, and mortality. Despite the availability of consensus-based diagnostic criteria, its identification in clinical practice remains limited due to reliance on specialized assessments and resource-intensive measurements. Artificial intelligence (AI) and machine learning (ML) approaches have emerged as promising tools to enhance sarcopenia detection; however, evidence remains methodologically heterogeneous and has not been comprehensively synthesized. The objective was to systematically map the existing literature on AI/ML models developed to detect or predict sarcopenia, describing their methodological characteristics, input features, model performance, validation strategies, and adherence to reporting standards. Methods: A scoping review was conducted following PRISMA-ScR guidelines. Searches were performed in five databases (MEDLINE, Scopus, SciELO, Web of Science, and LILACS) from inception to 28 February 2026. Studies were included if they developed and/or validated AI/ML models for binary classification of sarcopenia using recognized consensus definitions. Two reviewers independently screened studies, extracted data, and assessed adherence to TRIPOD+AI reporting recommendations and appraised methodological quality using the NHLBI Quality Assessment Tool. Findings were synthesized descriptively. The review protocol was registered in the Open Science Framework. Results: Of 2910 records, 28 studies (n = 34,498 participants in the primary analytical cohorts, with an additional 2800 participants in independent external validation cohorts) were included, predominantly from Asia (China n = 14, South Korea n = 7). Random Forest was the most frequent algorithm (n = 6), followed by voting classifiers, MLP, and XGBoost (n = 4 each). Clinical tabular data, including anthropometric and laboratory variables, were the most common input features. Model performance was generally high, with AUC values ranging from 0.710 to 0.975 (mean ≈ 0.869), although heterogeneity across populations and validation strategies was substantial. External validation was performed in only 7 of the 28 studies (25%). No study fully adhered to TRIPOD+AI recommendations; mean compliance was moderate, with critical gaps in code sharing, patient/public involvement, external validation, and subgroup performance reporting. Conclusions: AI/ML models, particularly ensemble methods using accessible clinical variables, showed high discrimination in model development settings, with performance estimates that derive predominantly from internal validation and are not comparable across studies. However, important methodological limitations, including lack of external validation, limited generalizability, and suboptimal adherence to reporting standards, were observed. Future research should prioritize external validation in diverse populations, transparent reporting following TRIPOD+AI, and open sharing of code and data to facilitate clinical translation.
- 26 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8320
Open AccessExploring Artificial Intelligence Models for the Detection and Prediction of Sarcopenia: A Scoping Review
Background/Objectives: Sarcopenia is a progressive skeletal muscle disorder associated with adverse health outcomes, including disability, hospitalization, and mortality. Despite the availability of consensus-based diagnostic criteria, its identification in clinical practice remains limited due to reliance on specialized assessments and resource-intensive measurements. Artificial intelligence (AI) and machine learning (ML) approaches have emerged as promising tools to enhance sarcopenia detection; however, evidence remains methodologically heterogeneous and has not been comprehensively synthesized. The objective was to systematically map the existing literature on AI/ML models developed to detect or predict sarcopenia, describing their methodological characteristics, input features, model performance, validation strategies, and adherence to reporting standards. Methods: A scoping review was conducted following PRISMA-ScR guidelines. Searches were performed in five databases (MEDLINE, Scopus, SciELO, Web of Science, and LILACS) from inception to 28 February 2026. Studies were included if they developed and/or validated AI/ML models for binary classification of sarcopenia using recognized consensus definitions. Two reviewers independently screened studies, extracted data, and assessed adherence to TRIPOD+AI reporting recommendations and appraised methodological quality using the NHLBI Quality Assessment Tool. Findings were synthesized descriptively. The review protocol was registered in the Open Science Framework. Results: Of 2910 records, 28 studies (n = 34,498 participants in the primary analytical cohorts, with an additional 2800 participants in independent external validation cohorts) were included, predominantly from Asia (China n = 14, South Korea n = 7). Random Forest was the most frequent algorithm (n = 6), followed by voting classifiers, MLP, and XGBoost (n = 4 each). Clinical tabular data, including anthropometric and laboratory variables, were the most common input features. Model performance was generally high, with AUC values ranging from 0.710 to 0.975 (mean ≈ 0.869), although heterogeneity across populations and validation strategies was substantial. External validation was performed in only 7 of the 28 studies (25%). No study fully adhered to TRIPOD+AI recommendations; mean compliance was moderate, with critical gaps in code sharing, patient/public involvement, external validation, and subgroup performance reporting. Conclusions: AI/ML models, particularly ensemble methods using accessible clinical variables, showed high discrimination in model development settings, with performance estimates that derive predominantly from internal validation and are not comparable across studies. However, important methodological limitations, including lack of external validation, limited generalizability, and suboptimal adherence to reporting standards, were observed. Future research should prioritize external validation in diverse populations, transparent reporting following TRIPOD+AI, and open sharing of code and data to facilitate clinical translation.
- 30 June 2026
- Published by Fundación Alimentación Saludable in Nutrición Clínica y Dietética Hospitalaria
- p. 393-405
Correlation between sarcopenia and its clinical criteria with the quality of life of older adults with Chronic Obstructive Pulmonary Disease
Introduction: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of disability and mortality worldwide. The presence of sarcopenia in this population has an impact on physical function and quality of life. Identifying sarcopenia in people with COPD allows for the development of personalized rehabilitation strategies. Objective: To analyze the correlation between the clinical criteria for sarcopenia (muscle mass, muscle strength, and physical performance) and quality of life in older adults with COPD. Methods: This is an analytical cross-sectional study with a convenience sample consisting of thirty-seven adults aged 60 years or older with COPD diagnosed according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Muscle mass was assessed using bioelectrical impedance analysis; handgrip strength was measured with a digital dynamometer; and physical performance was evaluated using 4-meter gait speed. Quality of life was assessed with the COPD Assessment Test (CAT). Pearson or Spearman correlation coefficients were calculated according to data distribution, with significance set at p < 0.05. Multivariable linear regression models adjusted for age, comorbidity burden, and GOLD stage were used to identify independent associations with CAT scores. Results: The study included 37 people with COPD. The total CAT score demonstrated significant negative correlations with handgrip strength (r = –0,591; CI 95%: [-0,8244 to -0,1883]; p = 0,007), skeletal muscle mass index (r = –0,515; CI 95%: [-0,7695 to -0,1193]; p = 0,014), free-fat mass (r = –0,514; CI 95%: [-0,7691 to -0,1183]; p = 0,014), and fat-free mass index (r = –0,430; CI 95%: [-0,7213 to -0,01109]; p = 0,045) (n = 37 for all the analysis). Among individual CAT components, “chest tightness,” “activities,” “confidence,” and “energy” showed the strongest associations with sarcopenia-related clinical criteria, with correlation coefficients ranging from –0.437 to –0.731. In the adjusted analyses, handgrip strength was the only variable independently associated with quality of life (β = –0.359; 95% CI: –0.678 to –0.039; p = 0.030). Conclusion: Lower muscle mass and reduced muscle strength were correlated with greater symptom burden and poorer quality of life in older adults with COPD. The CAT items related to daily activities, confidence, and energy showed the strongest associations with sarcopenia criteria, underscoring the relevance of evaluating muscle health in this population. After adjusted analysis, handgrip strength emerged as the only independent predictor of quality of life.
- 30 June 2026
- Published by Fundación Alimentación Saludable in Nutrición Clínica y Dietética Hospitalaria
- p. 393-405
Correlation between sarcopenia and its clinical criteria with the quality of life of older adults with Chronic Obstructive Pulmonary Disease
Introduction: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of disability and mortality worldwide. The presence of sarcopenia in this population has an impact on physical function and quality of life. Identifying sarcopenia in people with COPD allows for the development of personalized rehabilitation strategies. Objective: To analyze the correlation between the clinical criteria for sarcopenia (muscle mass, muscle strength, and physical performance) and quality of life in older adults with COPD. Methods: This is an analytical cross-sectional study with a convenience sample consisting of thirty-seven adults aged 60 years or older with COPD diagnosed according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Muscle mass was assessed using bioelectrical impedance analysis; handgrip strength was measured with a digital dynamometer; and physical performance was evaluated using 4-meter gait speed. Quality of life was assessed with the COPD Assessment Test (CAT). Pearson or Spearman correlation coefficients were calculated according to data distribution, with significance set at p < 0.05. Multivariable linear regression models adjusted for age, comorbidity burden, and GOLD stage were used to identify independent associations with CAT scores. Results: The study included 37 people with COPD. The total CAT score demonstrated significant negative correlations with handgrip strength (r = –0,591; CI 95%: [-0,8244 to -0,1883]; p = 0,007), skeletal muscle mass index (r = –0,515; CI 95%: [-0,7695 to -0,1193]; p = 0,014), free-fat mass (r = –0,514; CI 95%: [-0,7691 to -0,1183]; p = 0,014), and fat-free mass index (r = –0,430; CI 95%: [-0,7213 to -0,01109]; p = 0,045) (n = 37 for all the analysis). Among individual CAT components, “chest tightness,” “activities,” “confidence,” and “energy” showed the strongest associations with sarcopenia-related clinical criteria, with correlation coefficients ranging from –0.437 to –0.731. In the adjusted analyses, handgrip strength was the only variable independently associated with quality of life (β = –0.359; 95% CI: –0.678 to –0.039; p = 0.030). Conclusion: Lower muscle mass and reduced muscle strength were correlated with greater symptom burden and poorer quality of life in older adults with COPD. The CAT items related to daily activities, confidence, and energy showed the strongest associations with sarcopenia criteria, underscoring the relevance of evaluating muscle health in this population. After adjusted analysis, handgrip strength emerged as the only independent predictor of quality of life.
- Open Access
- 6 April 2026
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 20, 1-10
Geographical, methodological, and thematic trends in clinical trial protocols on exercise and physical activity in older adults in Latin America and the Caribbean
Objective: To describe the geographic, methodological, and thematic characteristics of clinical trial protocols on exercise and physical activity interventions for older adults in Latin America and the Caribbean. Methods: This cross-sectional descriptive study was based on an analysis of secondary records of a review of clinical trial protocols registered in the ClinicalTrials.gov database to identify protocols registered until June 2025. Eligible trials targeted adults ≥ 65 years of age, included exercise or physical activity as a primary intervention, and were conducted in Latin America and the Caribbean. The extracted data included country, intervention type, study design, recruitment status, outcomes, and funding source. Interventions were classified into 9 categories. Descriptive statistics were used to summarize the findings. Results: A total of 185 protocols from 27,518 screened records met the inclusion criteria. Most were from Brazil (81.6%), followed by Chile (8.6%) and Mexico (5.4%). Muscle strengthening (19.7%) and multicomponent physical activity (18.1%) were the most frequent types, while 33.5% included non-conventional modalities, such as aquatic therapy, dance-based programs, Tai Chi, yoga, exergaming, and electrostimulation. Motor function was the most common primary outcome (39.5%). Most studies were completed (59.5%) and primarily funded by universities, with minimal involvement from industry (0.5%). Conclusions: This is the first registry-based analysis of exercise and physical activity trial protocols for older adults in Latin America and the Caribbean, revealing a strong concentration in Brazil, a focus on muscle strengthening and multicomponent programs, and emerging innovative modalities. The limited outcome diversity and minimal private sector involvement highlight key gaps that should be addressed to strengthen the region’s research capacity and impact.
- 6 April 2026
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 20, 1-10
Open AccessGeographical, methodological, and thematic trends in clinical trial protocols on exercise and physical activity in older adults in Latin America and the Caribbean
Objective: To describe the geographic, methodological, and thematic characteristics of clinical trial protocols on exercise and physical activity interventions for older adults in Latin America and the Caribbean. Methods: This cross-sectional descriptive study was based on an analysis of secondary records of a review of clinical trial protocols registered in the ClinicalTrials.gov database to identify protocols registered until June 2025. Eligible trials targeted adults ≥ 65 years of age, included exercise or physical activity as a primary intervention, and were conducted in Latin America and the Caribbean. The extracted data included country, intervention type, study design, recruitment status, outcomes, and funding source. Interventions were classified into 9 categories. Descriptive statistics were used to summarize the findings. Results: A total of 185 protocols from 27,518 screened records met the inclusion criteria. Most were from Brazil (81.6%), followed by Chile (8.6%) and Mexico (5.4%). Muscle strengthening (19.7%) and multicomponent physical activity (18.1%) were the most frequent types, while 33.5% included non-conventional modalities, such as aquatic therapy, dance-based programs, Tai Chi, yoga, exergaming, and electrostimulation. Motor function was the most common primary outcome (39.5%). Most studies were completed (59.5%) and primarily funded by universities, with minimal involvement from industry (0.5%). Conclusions: This is the first registry-based analysis of exercise and physical activity trial protocols for older adults in Latin America and the Caribbean, revealing a strong concentration in Brazil, a focus on muscle strengthening and multicomponent programs, and emerging innovative modalities. The limited outcome diversity and minimal private sector involvement highlight key gaps that should be addressed to strengthen the region’s research capacity and impact.
- Open Access
- 2 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3225
Connecting the Dots: Neurobiological Interplay Between Type 2 Diabetes and Alzheimer’s Disease
Diabetes Mellitus is a chronic metabolic disorder characterized by impaired insulin production and/or action, leading to persistent hyperglycemia and insulin resistance. It has been associated with several comorbidities, including cognitive dysfunction, affecting functions such as attention, memory, and processing speed. Mounting evidence indicates a complex relationship between type 2 Diabetes Mellitus (DM2) and neurodegenerative disorders such as mild cognitive impairment and Alzheimer’s disease (AD). Beyond the conventional hallmarks of each pathology, patients with DM2 face an increased risk of neuronal degeneration, while AD is characterized by a marked reduction in insulin receptor density. Although aging, neuroinflammation, and vascular dysfunction have been recognized as key risk factors in AD, the precise molecular mechanisms driving AD pathogenesis remain incompletely understood. Various studies have been conducted to identify reliable biomarkers that elucidate the connection between DM2 and AD, including insulin dysregulation, neuroinflammation, amyloid-β aggregation, and tau hyperphosphorylation. Investigation of these biomarkers is still ongoing, and they may serve not only as diagnostic tools but also as therapeutic targets. Here, we review the current evidence supporting a convergent biological framework between DM2 and AD. Clarifying these shared pathways may improve early detection and guide the development of targeted therapeutic strategies aimed at reducing neurodegeneration in metabolically vulnerable populations.
- 2 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3225
Open AccessConnecting the Dots: Neurobiological Interplay Between Type 2 Diabetes and Alzheimer’s Disease
Diabetes Mellitus is a chronic metabolic disorder characterized by impaired insulin production and/or action, leading to persistent hyperglycemia and insulin resistance. It has been associated with several comorbidities, including cognitive dysfunction, affecting functions such as attention, memory, and processing speed. Mounting evidence indicates a complex relationship between type 2 Diabetes Mellitus (DM2) and neurodegenerative disorders such as mild cognitive impairment and Alzheimer’s disease (AD). Beyond the conventional hallmarks of each pathology, patients with DM2 face an increased risk of neuronal degeneration, while AD is characterized by a marked reduction in insulin receptor density. Although aging, neuroinflammation, and vascular dysfunction have been recognized as key risk factors in AD, the precise molecular mechanisms driving AD pathogenesis remain incompletely understood. Various studies have been conducted to identify reliable biomarkers that elucidate the connection between DM2 and AD, including insulin dysregulation, neuroinflammation, amyloid-β aggregation, and tau hyperphosphorylation. Investigation of these biomarkers is still ongoing, and they may serve not only as diagnostic tools but also as therapeutic targets. Here, we review the current evidence supporting a convergent biological framework between DM2 and AD. Clarifying these shared pathways may improve early detection and guide the development of targeted therapeutic strategies aimed at reducing neurodegeneration in metabolically vulnerable populations.
- 4 March 2026
- Published by Fundación Alimentación Saludable in Nutrición Clínica y Dietética Hospitalaria
- Vol. 46 (1) , 349-355
Cuartiles del ángulo de fase y mortalidad por todas las causas en adultos mayores: un estudio de cohorte longitudinal.
Introduction: Phase angle (PhA) derived from bioelectrical impedance analysis (BIA) is a non-invasive biomarker that reflects cell membrane integrity and nutritional status. Although several cut-off points have been proposed to identify high-risk individuals, the relationship between PhA quartiles and mortality risk has not been systematically explored. Objective: This study aimed to evaluate the association between quartiles of PhA and all-cause mortality in older adults. Methods: In this prospective cohort study, PhA was measured at baseline using standardized BIA procedures, and participants were stratified into quartiles (Q1–Q4) according to the distribution of PhA values. Mortality and follow-up time were recorded. Cox proportional hazards models were applied to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for each quartile, using Q1 as reference. Model 1 was unadjusted, Model 2 adjusted for age and sex, and Model 3 further adjusted for the Charlson Comorbidity Index. Results: A total of 398 older adults were analyzed. Participants in higher PhA quartiles had lower comorbidity scores and improved survival. In the fully adjusted model, HRs (95% CI) for Q2, Q3, and Q4 versus Q1 were 0.48 (0.24–0.95), 0.43 (0.20–0.91), and 0.27 (0.11–0.67), respectively (p-trend = 0.002). Each increment in PhA quartile corresponded to a substantial reduction in mortality risk, indicating a robust dose-response relationship independent of age, sex, and multimorbidity. Conclusions: Quartile-based analysis revealed a graded, inverse relationship between PhA and mortality. Higher PhA values independently predicted greater survival, supporting its use as an accessible biomarker for risk stratification and early intervention in geriatric care.
- 4 March 2026
- Published by Fundación Alimentación Saludable in Nutrición Clínica y Dietética Hospitalaria
- Vol. 46 (1) , 349-355
Cuartiles del ángulo de fase y mortalidad por todas las causas en adultos mayores: un estudio de cohorte longitudinal.
Introduction: Phase angle (PhA) derived from bioelectrical impedance analysis (BIA) is a non-invasive biomarker that reflects cell membrane integrity and nutritional status. Although several cut-off points have been proposed to identify high-risk individuals, the relationship between PhA quartiles and mortality risk has not been systematically explored. Objective: This study aimed to evaluate the association between quartiles of PhA and all-cause mortality in older adults. Methods: In this prospective cohort study, PhA was measured at baseline using standardized BIA procedures, and participants were stratified into quartiles (Q1–Q4) according to the distribution of PhA values. Mortality and follow-up time were recorded. Cox proportional hazards models were applied to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for each quartile, using Q1 as reference. Model 1 was unadjusted, Model 2 adjusted for age and sex, and Model 3 further adjusted for the Charlson Comorbidity Index. Results: A total of 398 older adults were analyzed. Participants in higher PhA quartiles had lower comorbidity scores and improved survival. In the fully adjusted model, HRs (95% CI) for Q2, Q3, and Q4 versus Q1 were 0.48 (0.24–0.95), 0.43 (0.20–0.91), and 0.27 (0.11–0.67), respectively (p-trend = 0.002). Each increment in PhA quartile corresponded to a substantial reduction in mortality risk, indicating a robust dose-response relationship independent of age, sex, and multimorbidity. Conclusions: Quartile-based analysis revealed a graded, inverse relationship between PhA and mortality. Higher PhA values independently predicted greater survival, supporting its use as an accessible biomarker for risk stratification and early intervention in geriatric care.
- Open Access
- 27 February 2026
- Published by MDPI AG in Preprints.org
Connecting the Dots: Neurobiological Interplay Between Type 2 Diabetes and Alzheimer’s Disease
Diabetes Mellitus is a chronic metabolic disorder characterized by impaired insulin production and/or action, leading to persistent hyperglycemia and insulin resistance. It has been associated with several comorbidities, including cognitive dysfunction, affecting functions such as attention, memory, and processing speed. Mounting evidence indicates a complex relationship between type 2 Diabetes Mellitus (DM2) and neurodegenerative disorders such as mild cognitive impairment and Alzheimer’s disease (AD). Beyond the conventional hallmarks of each pathology, patients with DM2 face an increased risk of neuronal degeneration, while AD is characterized by a marked reduction in insulin receptor density. Although aging, neuroinflammation, and vascular dysfunction have been recognized as key risk factors in AD, the precise molecular mechanisms driving AD pathogenesis remain incompletely understood. Various studies have been conducted to identify reliable biomarkers that elucidate the connection between DM2 and AD, including insulin dysregulation, neuroinflammation, amyloid-β aggregation, and tau hyperphosphorylation. Investigation on these biomarkers is still ongoing and may serve not only as diagnostic tools but also as therapeutic targets. Here, we review the current evidence supporting a convergent biological framework between DM2 and AD. Clarifying these shared pathways may improve early detection and guide the development of targeted therapeutic strategies aimed at reducing neurodegeneration in metabolically vulnerable populations.
- 27 February 2026
- Published by MDPI AG in Preprints.org
Open AccessConnecting the Dots: Neurobiological Interplay Between Type 2 Diabetes and Alzheimer’s Disease
Diabetes Mellitus is a chronic metabolic disorder characterized by impaired insulin production and/or action, leading to persistent hyperglycemia and insulin resistance. It has been associated with several comorbidities, including cognitive dysfunction, affecting functions such as attention, memory, and processing speed. Mounting evidence indicates a complex relationship between type 2 Diabetes Mellitus (DM2) and neurodegenerative disorders such as mild cognitive impairment and Alzheimer’s disease (AD). Beyond the conventional hallmarks of each pathology, patients with DM2 face an increased risk of neuronal degeneration, while AD is characterized by a marked reduction in insulin receptor density. Although aging, neuroinflammation, and vascular dysfunction have been recognized as key risk factors in AD, the precise molecular mechanisms driving AD pathogenesis remain incompletely understood. Various studies have been conducted to identify reliable biomarkers that elucidate the connection between DM2 and AD, including insulin dysregulation, neuroinflammation, amyloid-β aggregation, and tau hyperphosphorylation. Investigation on these biomarkers is still ongoing and may serve not only as diagnostic tools but also as therapeutic targets. Here, we review the current evidence supporting a convergent biological framework between DM2 and AD. Clarifying these shared pathways may improve early detection and guide the development of targeted therapeutic strategies aimed at reducing neurodegeneration in metabolically vulnerable populations.
- Open Access
- 25 November 2025
- Published by Fundación Alimentación Saludable in Nutrición Clínica y Dietética Hospitalaria
- Vol. 45 (4)
Social participation and cognitive health in older adults: A scoping review
Objective: To synthesize evidence on the association between social participation and cognitive health in older adults. Methods: A scoping review was conducted including 13 studies published between 2014 and 2025, with more than 100,000 participants from diverse cultural contexts. Studies examined cognitive domains, mechanisms, and outcomes related to social participation. Results: Social participation was consistently associated with better cognitive performance, particularly in episodic memory, attention, executive function, and verbal fluency. Mechanistic pathways included stimulation of neuroplasticity, stress regulation via neuroendocrine modulation, enhancement of emotional regulation, and reinforcement of personal and group identity. Social participation also buffered against depressive symptoms, loneliness, and functional decline, and contributed to structural and functional brain preservation. Although most studies were observational, converging evidence indicates that social participation is a modifiable factor linked to reduced risk of cognitive impairment and dementia. Cross-cultural heterogeneity highlights the need for strategies tailored to cultural and contextual factors in aging populations. Conclusion: Social participation should be considered an integral element of preventive and therapeutic approaches for cognitive health. Group-based interventions, including community programs, volunteering, cultural or religious activities, and intergenerational initiatives, show particular promise. Future longitudinal and multimodal research is needed to clarify causal mechanisms and guide the integration of social participation into evidence-based frameworks for healthy aging.
- 25 November 2025
- Published by Fundación Alimentación Saludable in Nutrición Clínica y Dietética Hospitalaria
- Vol. 45 (4)
Open AccessSocial participation and cognitive health in older adults: A scoping review
Objective: To synthesize evidence on the association between social participation and cognitive health in older adults. Methods: A scoping review was conducted including 13 studies published between 2014 and 2025, with more than 100,000 participants from diverse cultural contexts. Studies examined cognitive domains, mechanisms, and outcomes related to social participation. Results: Social participation was consistently associated with better cognitive performance, particularly in episodic memory, attention, executive function, and verbal fluency. Mechanistic pathways included stimulation of neuroplasticity, stress regulation via neuroendocrine modulation, enhancement of emotional regulation, and reinforcement of personal and group identity. Social participation also buffered against depressive symptoms, loneliness, and functional decline, and contributed to structural and functional brain preservation. Although most studies were observational, converging evidence indicates that social participation is a modifiable factor linked to reduced risk of cognitive impairment and dementia. Cross-cultural heterogeneity highlights the need for strategies tailored to cultural and contextual factors in aging populations. Conclusion: Social participation should be considered an integral element of preventive and therapeutic approaches for cognitive health. Group-based interventions, including community programs, volunteering, cultural or religious activities, and intergenerational initiatives, show particular promise. Future longitudinal and multimodal research is needed to clarify causal mechanisms and guide the integration of social participation into evidence-based frameworks for healthy aging.
- Open Access
Generativity and Psychological Well-Being in Primary and Secondary Teachers: A Systematic Review
Background: Teaching represents a highly demanding profession in emotional, social and cognitive terms, demanding a genuine interest in contributing to the development of future generations. Precisely for this reason, generativity, understood as the genuine interest in contributing to the care and development of future generations, and psychological well-being, defined as the integration of autonomy, life purpose and positive relationships, are key variables to understand the integral development of teachers. However, the relationship between both constructions in primary and secondary school teachers emerges as an emerging theme that is scarcely researched in the local context. Method: Following the PRISMA-ScR guidelines, this exploratory review used WOS, Scopus, ERIC, Scielo, and PsycNet databases to analyze the available literature on the interplay between generativity and psychological well-being in primary or secondary school teachers exploring its manifestations and the contextual factors (rural/urban) that shape this dynamic. We included 11 studies published up to 2025. Results: The studies analyzed show that generativity strengthens the sense of life and teacher commitment, while psychological well-being would modulate resilience to stress and pedagogical effectiveness. However, the literature presents conceptual and methodological heterogeneity. The theoretical gaps and methodological limitations of the findings are discussed, highlighting the importance of moving towards integrative frameworks that strengthen the mental health of teachers in the digital society. Conclusion: Generativity and psychological well-being are deeply interconnected in teaching practice yet remain under-theorized in educational research. This review highlights the need for integrative frameworks that support teachers’ mental health and professional identity, especially in diverse and evolving educational contexts.
Open AccessGenerativity and Psychological Well-Being in Primary and Secondary Teachers: A Systematic Review
Background: Teaching represents a highly demanding profession in emotional, social and cognitive terms, demanding a genuine interest in contributing to the development of future generations. Precisely for this reason, generativity, understood as the genuine interest in contributing to the care and development of future generations, and psychological well-being, defined as the integration of autonomy, life purpose and positive relationships, are key variables to understand the integral development of teachers. However, the relationship between both constructions in primary and secondary school teachers emerges as an emerging theme that is scarcely researched in the local context. Method: Following the PRISMA-ScR guidelines, this exploratory review used WOS, Scopus, ERIC, Scielo, and PsycNet databases to analyze the available literature on the interplay between generativity and psychological well-being in primary or secondary school teachers exploring its manifestations and the contextual factors (rural/urban) that shape this dynamic. We included 11 studies published up to 2025. Results: The studies analyzed show that generativity strengthens the sense of life and teacher commitment, while psychological well-being would modulate resilience to stress and pedagogical effectiveness. However, the literature presents conceptual and methodological heterogeneity. The theoretical gaps and methodological limitations of the findings are discussed, highlighting the importance of moving towards integrative frameworks that strengthen the mental health of teachers in the digital society. Conclusion: Generativity and psychological well-being are deeply interconnected in teaching practice yet remain under-theorized in educational research. This review highlights the need for integrative frameworks that support teachers’ mental health and professional identity, especially in diverse and evolving educational contexts.